Health Care & Life Sciences » Biotechnology | Panacos Pharmaceuticals Inc.

Panacos Pharmaceuticals Inc.

Panacos Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
53.64 M
Public Float
52.48 M

Profile

Address
134 Coolidge Avenue
Watertown Massachusetts 02472
United States
Employees -
Website http://www.panacos.com
Updated 07/08/2019
Panacos Pharmaceuticals, Inc. is a development stage company engaged in the discovery and development of small-molecule oral drug which is designed to treat Human Immunodeficiency Virus and other major human viral diseases. Its primary product is Bevirimat which is an oral human immunodeficiency virus which provides a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in March 2005 and is headquartered in Watertown, MA.

Financials

View All
Created with Highcharts 5.0.14Panacos Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4 5084 50812 03812 03859 07859 07838 11038 11037 45937 45920032004200520062007010k20k30k40k50k60k70k
Created with Highcharts 5.0.14Panacos Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 0771 0771 3361 3361 0491 049284284180180200320042005200620070250500750100012501500

John R. Barr
President & Chief Executive Officer
Thomas T. Higgins
Chief Financial Officer